Key result
Endothelin-1 increased left ventricular systolic pressure from 111 to 134 mmHg under constant coronary flow, demonstrating positive inotropic effects and increased diastolic stiffness.
Why the study?
Does endothelin-1 modulate systolic and diastolic function in isolated rat hearts?
Does endothelin-1 modulate systolic and diastolic function in isolated rat hearts?
Endothelin-1 possesses positive inotropic effects and increases diastolic stiffness, but these effects may be masked by vasoconstriction-induced ischemia.
Answers are grounded in this paper and cite their sources.
Endothelin-1 effects on contractility warrant targeted human studies; leaves open net in vivo impact and clinical relevance.
Different conclusions have been reached with regard to the effect of endothelin (ET-1) on cardiac contractility. We examined systolic and diastolic function in response to constant known concentrations of ET-1 with or without ET-1 induced reductions in coronary flow (CF). Rat hearts (n = 21) were buffer-perfused using constant coronary flow (cCF) or constant perfusion pressure (cPP). Left ventricular function was assessed isovolumically. Addition of ET-1 (10(-9) M) in the cCF group caused a gradual increase in PP from 61 +/- 2 to 165 +/- 6 mmHg (mean +/- SE) (P < 0.01). Within 10 min left ventricular systolic pressure (LVSP) increased from 111 +/- 2 to a maximum of 134 +/- 4 mmHg (P < 0.01) and [LVdP/dt] increased from 1640 +/- 81 to a maximum of 2020 +/- 92 mmHg s-1 (P < 0.01). After 15 min left ventricular end diastolic pressure (LVEDP), a measure of diastolic stiffness (DS), also increased. With ET-1 (10(-8) M), similar haemodynamic alterations appeared more rapidly. In the cPP group, ET-1 (10(-9) M) caused a sharp decrease in CF and LVSP fell from 115 +/- 8 to 62 +/- 12 mmHg at 10 min (P < 0.001). Systolic function remained stable at a reduced level for 1 h. DS did not change. Thus, ET-1 possesses positive inotropic effects and increases diastolic stiffness. Both effects may be masked by vasoconstriction-induced ischaemia.
No takes yet. Share an insight, caveat, or question.
Offstad et al. (1995) studied this question. Endothelin-1 (ET-1) vs. Baseline / Constant perfusion pressure was evaluated on Left ventricular systolic pressure (LVSP) (p=<0.01). Endothelin-1 increased left ventricular systolic pressure from 111 to 134 mmHg under constant coronary flow, demonstrating positive inotropic effects and increased diastolic stiffness.
Synapse has enriched 10 related papers. Consider them for comparative context: